(Press-News.org) OAK BROOK, Ill. – New research from the Netherlands shows that the switch from screen film mammography (SFM) to digital mammography (DM) in large, population-based breast cancer screening programs improves the detection of life-threatening cancer without significantly increasing detection of clinically insignificant disease. Results of the study are published online in the journal Radiology.
DM's higher sensitivity at detecting breast cancer raised concerns that its introduction into screening programs would increase the diagnosis of clinically unimportant cancers—cancers that, if left undetected and therefore untreated, would never have surfaced clinically in the person's lifetime. Data analysis showed an increased incidence of ductal carcinoma in situ (DCIS), a precursor for invasive breast cancer, in the years after the introduction of population-based screening with DM. The development of low-grade DCIS can extend over more than three decades; however, high-grade DCIS is associated with far more rapid cancer invasion.
"More DCIS and invasive cancers are detected with the use of DM in breast cancer screening compared to SFM," said Adriana M.J. Bluekens, M.D., from the National Expert and Training Centre for Breast Cancer Screening in Nijmegen and St. Elisabeth Hospital in Tilburg, both in the Netherlands. "In the mix of low- to high-grade DCIS lesions, there is no shift to the detection of low-grade lesions in digital screening. Instead of this, we noticed a larger amount of high-grade lesions, which are regarded as precursors of high-grade invasive tumors."
To learn more about the impact of DM on screening programs, Dutch researchers compared it with SFM in screening mammograms performed between 2003 and 2007. Recall was indicated in 18,896 cases out of almost two million mammograms studied, and 6,410 women were diagnosed with breast cancer. As expected, DM had a higher initial sensitivity for detecting cancer, with a detection rate per thousand of 6.8, compared with 5.6 for SFM.
Detection of high-grade DCIS with DM was 58.5 percent, compared with 50.5 percent for SFM.
"This gain is largely due to enhanced depiction of microcalcifications with DM resulting in improved detection of DCIS and invasive carcinoma with an intraductal component," Dr. Bluekens said.
The initial recall rate was higher with DM: 4.4 percent, compared with 2.6 percent for SFM. However, the transition to digital mammography did not result in a disproportionate increase in low-grade DCIS lesions, which are linked to possible overdiagnosis.
The findings provide further evidence of the benefits of population-based breast cancer screening programs that use DM, according to Dr. Bluekens.
"The follow-up period of the different digital screening programs is not sufficiently long enough to analyze mortality effect separately from that of SFM," she noted. "However, surrogate parameters, such as stage distribution and tumor characteristics of DM-detected cancers, do indicate the continuation of mortality decrease with the transformation of SFM to DM in screening programs."
Researchers cautioned that the results were based on analysis of data from the Dutch screening program, with its focus on balancing the rates of detection, recall and false-positives. Numbers from the U.S. screening program, which focuses more on a high detection rate, would likely be different.
###"Comparison of Digital Screening Mammography and Screen-Film Mammography in the Early Detection of Clinically Relevant Cancers: A Multicenter Study." Collaborating with Dr. Bluekens were Roland Holland, M.D., Ph.D., Nico Karssemeijer, Ph.D., Mireille J.M. Broeders, Ph.D., and Gerard J den Heeten, M.D., Ph.D.
Radiology is edited by Herbert Y. Kressel, M.D., Harvard Medical School, Boston, Mass., and owned and published by the Radiological Society of North America, Inc. (http://radiology.rsna.org/)
RSNA is an association of more than 50,000 radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation.
The Society is based in Oak Brook, Ill. (RSNA.org)
For patient-friendly information on mammography, visit RadiologyInfo.org.
Digital mammography improves population-based breast cancer screening
2012-10-02
ELSE PRESS RELEASES FROM THIS DATE:
Novel MRI technique could reduce breast biopsies
2012-10-02
OAK BROOK, Ill. – Water diffusion measurements with MRI could decrease false-positive breast cancer results and reduce preventable biopsies, according to a new study published online in the journal Radiology. Researchers said the technique also could improve patient management by differentiating high-risk lesions requiring additional workup from other non-malignant subtypes.
Dynamic contrast-enhanced MRI (DCE-MRI) has emerged in recent years as a useful tool in breast cancer detection and staging. One of its primary limitations is a substantial number of false-positive ...
PETA scientists analyze animal use in HPV chemicals challenge program
2012-10-02
Washington — In an article published today (October 2, 2012) in the peer-reviewed journal Environmental Health Perspectives (EHP), People for the Ethical Treatment of Animals reports that the U.S. Environmental Protection Agency (EPA) High Production Volume (HPV) Chemicals Challenge Program had the potential to use 3.5 million animals in new testing, but after the application of animal-saving measures, approximately 127,000 were actually used. Although this toll in animal lives is high, it would have been many times worse had PETA not obtained major concessions from the ...
Provincial effort to improve stroke care in Alberta is 'paying off'
2012-10-02
Stroke care has improved considerably in Alberta following the implementation of the Alberta Provincial Stroke Strategy (APSS), leading to more targeted patient care and fewer health complications, according to a study presented today at the Canadian Stroke Congress.
Nearly 97 per cent of stroke patients received a brain-imaging scan during their admission to hospital in 2011, compared to 88 per cent before the APSS was implemented in 2006.
"The faster a patient has access to brain imaging, the faster they get the right diagnosis and the right treatment," says lead ...
Sleep apnea plays dual role in stroke
2012-10-02
Improvements to the diagnosis and screening of sleep apnea are critical to stroke prevention, according to new stroke care guidelines released today at the Canadian Stroke Congress.
Obstructive sleep apnea, a disorder where the flow of air to the brain pauses or decreases during sleep, is both a risk factor for stroke and a complication following stroke, according to the Canadian Best Practice Recommendations for Stroke Care.
Among the general population sleep apnea increases the likelihood of having a stroke, even after controlling for other stroke risk factors, such ...
Smoking clouds the brain after stroke
2012-10-02
A study of stroke patients from Southern Ontario found those who smoke have more difficulty with problem-solving and decision-making than non-smokers.
The study, presented today at the Canadian Stroke Congress, tested mental abilities of 76 patients, including 12 smokers, with an average age of 67.5 years, using the Montreal Cognitive Assessment (MoCA) tool. The MoCA exam tests patients with memory and problem solving questions and gives them a score out of 30.
Smokers had a median MoCA score two points lower than non-smokers -- 22 out of 30 compared to 24 out of 30. ...
Expand telestroke in all provinces to save lives, reduce disability
2012-10-02
Widespread use of telestroke -- two-way audiovisual linkups between neurologists in stroke centres and emergency rooms in underserved and rural areas -- would save lives, reduce disability and cut health-care costs in all parts of Canada, according to a major national report released today at the Canadian Stroke Congress.
However, despite repeated research that shows telestroke delivers quality stroke care to underserviced areas, few stroke patients in Canada are benefiting from this lifesaving service.
"The case for telestroke is compelling and the need is urgent," ...
Alzheimer's disease in men linked to low levels of hormone, IGF-1
2012-10-02
Chevy Chase, MD— Low serum levels of insulin-like growth factor-1 (IGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3) are associated with Alzheimer's Disease in men, but not women, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
IGF-1 and IGFBP-3 are involved in longevity and could be beneficial to cognition, especially in Alzheimer's disease where experimental studies have shown that IGF-1 opposes the main pathological processes of Alzheimer's disease. The current study ...
Study uncovers racial disparities in diabetic complications among underinsured
2012-10-02
Chevy Chase, MD— Diabetes is among the ten leading causes of death in both white and African American patients, but the prevalence of diabetic complications are race-specific, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
"This study is one of only a few to assess whether there is a racial difference in the incidence of diabetic complications," said Gang Hu, MD, PhD, of Pennington Biomedical Research Center in Baton Rouge, Louisiana, and lead author of the study. "Our findings suggest ...
New antibiotic cures disease by disarming pathogens, not killing them
2012-10-02
A new type of antibiotic can effectively treat an antibiotic-resistant infection by disarming instead of killing the bacteria that cause it. Researchers report their findings in the October 2 issue of mBio®, the online open-access journal of the American Society for Microbiology.
"Traditionally, people have tried to find antibiotics that rapidly kill bacteria. But we found a new class of antibiotics which has no ability to kill Acinetobacter that can still protect, not by killing the bug, but by completely preventing it from turning on host inflammation," says Brad Spellberg ...
Trojan horse drug therapy provides new approach to treating breast cancer
2012-10-02
When Linda Tuttle was diagnosed with breast cancer, she never imagined her experience would inspire her colleagues to design new treatments to tackle the disease.
An administrative assistant in the Department of Chemistry at Wake Forest University, Tuttle was more accustomed to talking to faculty and staff about meetings and course loads – not doctors' appointments and treatment plans.
But after her 2009 diagnosis, Tuttle's use of tamoxifen, a drug commonly used to treat breast cancer, inspired medicinal chemist Ulrich Bierbach to develop a targeted therapy that delivers ...